Logo Geneseeq
  • Services
    • Genomic Testing
      • Laboratory Developed Tests (LDT)
        • Solid Tumors
        • Hematologic Malignancies
        • Hereditary Cancers
        • Minimal Residual Disease
      • IVD Kit Solution
      • RUO Kit Solution
    • Research Services
      • Platforms
      • DNA Sequencing
      • RNA Sequencing
      • Other Services
  • Technology
    • Our Technology
    • Publications
  • Partnerships
  • About Us
    • What is Precision Oncology?
    • Our Company
    • Our Team
    • Certificates & Accreditation
  • News
  • Join Us
  • Contact Us
  • Ch|中文
  • Search

GENESEEQ

April 13, 2023

Geneseeq co-publish with UHN on using ctDNA as a prognostic biomarker for immunotherapy


0 Comments3 Minutes

April 11, 2023

Geneseeq to Present 13 Posters at AACR 2023


0 Comments3 Minutes

March 9, 2023

Geneseeq and Collaborators Initiate MOTION Study to Evaluate the Performance of Minimal Residual Disease Test SHIELDING™ in Early-stage Lung Cancer


0 Comments2 Minutes

January 24, 2023

Geneseeq receives CE Marks for MRD and MCED tests.


0 Comments2 Minutes

November 15, 2022

Geneseeq Publishes Promising Early Lung Cancer Detection Results in AJRCCM


0 Comments4 Minutes

November 3, 2022

Geneseeq study evaluates the clinical value of cell-free DNA 5’-end motif profile in the prediction of pathological complete response for LARC patients after neoadjuvant chemoradiotherapy


0 Comments3 Minutes

October 18, 2022

Geneseeq study highlights ctDNA monitoring clinical value in colorectal cancer patients resistant to BRAF/EGFR-targeted therapy


0 Comments3 Minutes

October 12, 2022

Interesting findings on ctDNA-based MRD detection in patients with resectable non-small cell lung cancer by Geneseeq


0 Comments4 Minutes

September 7, 2022

Geneseeq to present five posters at European Society for Medical Oncology 2022


0 Comments6 Minutes

August 3, 2022

GENESEEQ AND COLLABORATORS SHARE NEW FINDINGS AT WORLD CONFERENCE ON LUNG CANCER 2022


0 Comments10 Minutes

  • 1
  • 2
  • 3
  • 4
Logo Geneseeq

1-647-714-5020
1-800-362-0325
info.toronto@geneseeq.com

Quick Links
  • Services
  • Technology
  • News
  • About Us
Connect
  • Partnerships
  • Join us
  • Contact us
Privacy
  • Privacy Policy
  • Terms of Use
Headquarters

Main Office:
Suite 1802
393 University Avenue
Toronto, Ontario, M5G 1E6
Canada

© 2023 Geneseeq Technology Inc. | A Precision Oncology Company. All rights reserved

Privacy Preference Center

Privacy Preferences